KULKARNI SAMARTH (Chief Executive Officer) sold 1.6% of their position (4.10K shares) of CRISPR THERAPEUTICS AG on the open market
Open‑market sale worth $201.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/15/2026ACC: 0001193125-26-423056
DirectorOfficer· Chief Executive Officer
Since Sep 2018
-4.10K
Net shares
Net seller
$201.9K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
8.33K acquired · 12.43K disposed
Non-Derivative Transactions2
Common Shares
Direct
Shares
+8.33K
Price / share
—
Trade value
—
% of position
3.3%
10/13/2026
255.50K→263.83K
Common Shares
Direct
Shares
−4.10K
Price / share
$49.26
Trade value
$201.87K
% of position
1.6%
10/14/2026
263.83K→259.74K
Total
Net shares
+4.24K
Net value
-$201.87K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 10/13/2026 | M · Option Exercise | +8.33K | — | — | 3.3% | 255.50K | 263.83K |
| Common Shares Direct | 10/14/2026 | S · Sale | −4.10K | $49.26 | $201.87K | 1.6% | 263.83K | 259.74K |
| Total | +4.24K | -$201.87K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Shares
8.33K shares
Shares
−8.33K
Strike price
Held after
0.00
Exercisable
—
10/13/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Shares8.33K shares | 10/13/2026 | M · Option Exercise | −8.33K | — | 0.00 |